Equities

Pharmagreen Biotech Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PHBI:PKC

Pharmagreen Biotech Inc

Actions
  • Price (USD)0.002
  • Today's Change0.000 / -9.09%
  • Shares traded1.91m
  • 1 Year change+66.67%
  • Beta1.7628
Data delayed at least 15 minutes, as of Mar 02 2026 20:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pharmagreen Biotech, Inc. is a Canada-based nutraceutical company. The Company is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a variety of ailing conditions. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle of 60 enteric capsules. Its other nutraceutical products are in various development stages. Its products are marketed and are available through online stores, such as Amazon and Shopify.

  • Revenue in USD (TTM)3.01k
  • Net income in USD-226.26k
  • Incorporated2008
  • Employees0.00
  • Location
    Pharmagreen Biotech Inc2987 Blackbear CrtCOQUITLAM V3E 3A2CanadaCAN
  • Phone+1 (404) 671-9253
  • Websitehttps://www.pharmagreen.ca
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
International Stem Cell Corp9.39m-149.00k1.08m32.00----6.720.1152-0.0187-0.01871.170.06551.802.6611.08293,468.80-1.13-16.11-10.84-52.8857.8659.53-0.6283-10.910.46040.62580.8632--16.64-0.8308-59.54---19.12--
Herborium Group Inc340.33k-318.65k1.09m2.00------3.21-0.3492-0.34920.3672-1.162.323.8925.94---216.97-490.56----58.3156.36-93.63-186.810.0331-39.14----19.45-18.15120.44------
Halberd Corp281.24k25.34k1.13m3.000.6897--44.614.020.00230.00230.0018-0.00020.14490.03032.52--1.31--4.58--50.00--9.01--0.26611.351.02--271.52---60.11------
CDT Equity Inc0.00-20.70m1.28m6.00--0.2067-----473.79-473.790.003.350.00----0.00-358.56-----------------16.000.2881-------3,227.48------
Pharmagreen Biotech Inc3.01k-226.26k1.52m0.00----2.75505.30-0.0003-0.00030.00-0.00350.02860.20260.0669---214.92-709.50----44.85---7,518.27-147,637.600.0375------13.67---76.59------
GlucoTrack Inc0.00-25.85m1.57m11.00--0.5068-----1,225.32-1,225.320.003.060.00----0.00-567.22-147.48---192.87-----------3.510.5422-------218.40--34.73--
Exousia Pro Inc0.00-854.02k1.68m0.00---------0.0642-0.06420.00-0.03180.00-------1,313,877.00-----------------1,816.06---------248.31------
Virax Biolabs Group Ltd2.99k-5.64m1.69m19.00--0.2805--565.32-1.25-1.250.00070.81180.00040.53821.94157.37-74.60-111.16-77.64-133.38-1,515.05-4.50-189,095.00-7,009.4211.21-92.320.0959---95.95-42.409.98------
Clearmind Medicine Inc0.00-3.86m1.69m----0.1498-----30.64-30.640.007.540.00-------57.83-128.70-178.71-360.04------------0.5987------26.60------
Yubo International Biotech Ltd-20.00-1.23m1.77m18.00---------0.0099-0.00990.00-0.0098-0.00002-0.0005---1.11-105.87--------------0.2394-------99.43---48.55------
Carisma Therapeutics Inc52.63m8.04m1.79m46.000.2274--0.18750.0340.18810.18811.26-0.02082.17----1,144,174.0033.09-26.5851.48-30.35----15.28-169.12--------31.59--30.39---1.99--
Lyra Therapeutics Inc600.00k-32.95m1.79m30.00------2.99-23.78-23.780.418-2.630.0098----20,000.00-53.81-64.59-67.22-76.36-----5,491.17-5,844.58---------1.54---49.07--61.78--
Azitra Inc0.00-11.12m1.88m12.00--0.4304-----5.49-5.490.000.40660.00----0.00-157.91---203.88--------------0.1197---98.91--29.05------
CNS Pharmaceuticals Inc0.00-13.07m1.93m4.00--0.1803-----130.83-130.830.0017.250.00----0.00-135.60-153.00-197.11-237.57------------0.0031------21.18---26.93--
Bluejay Diagnostics Inc0.00-20.07m1.99m7.00--0.2275-----134.42-134.420.009.010.00----0.00-103.46-70.71-124.04-82.92-------12,694.84----0.0028-------110.38--119.51--
Agentix Corp0.00-590.30k2.00m-----------0.0147-0.01470.00-0.08730.00-------735.53-----------------11.76--------3.09------
Data as of Mar 02 2026. Currency figures normalised to Pharmagreen Biotech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.